Recombinant protein vaccines, a proven approach against coronavirus pandemics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Authors
Keywords
SARS-CoV-2, COVID-19, Adjuvants, Vaccine production, Vaccine delivery, Clinical trials, Neutralizing antibodies, Th1
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 170, Issue -, Pages 71-82
Publisher
Elsevier BV
Online
2021-01-08
DOI
10.1016/j.addr.2021.01.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- The role of IgA in COVID-19
- (2020) Yin Xia Chao et al. BRAIN BEHAVIOR AND IMMUNITY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
- (2020) Maopeng Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Laboratory Diagnosis of COVID-19: Current Issues and Challenges
- (2020) Yi-Wei Tang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
- (2020) Peter J. Hotez et al. MICROBES AND INFECTION
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
- (2020) Mario Amacker et al. npj Vaccines
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus
- (2020) V. V. Oberemok et al. INFLAMMATION RESEARCH
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- SARS-CoV-2 vaccines: ‘Warp Speed’ needs mind melds not warped minds
- (2020) John P. Moore et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
- (2020) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study
- (2020) Neil Goldstein et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- (2020) Tsun-Yung Kuo et al. Scientific Reports
- A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
- (2019) B. Owczarek et al. Biomed Research International
- Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
- (2019) E. Criscuolo et al. Journal of Immunology Research
- Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
- (2019) Catherine Cohet et al. VACCINE
- Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing
- (2019) John Puetz et al. Processes
- Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
- (2019) Robert Heddle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
- (2019) Nagesh K. Tripathi et al. Frontiers in Bioengineering and Biotechnology
- Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
- (2018) Sofia E. Magnusson et al. IMMUNOLOGIC RESEARCH
- Immunology and efficacy of MF59-adjuvanted vaccines
- (2018) Eun-Ju Ko et al. Human Vaccines & Immunotherapeutics
- Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
- (2018) Jasmine Tomar et al. JOURNAL OF CONTROLLED RELEASE
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
- (2018) John D. Clements et al. mSphere
- Emerging experience with meningococcal serogroup B protein vaccines
- (2017) Daniela Toneatto et al. Expert Review of Vaccines
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
- (2017) Yoshikazu Honda-Okubo et al. Human Vaccines & Immunotherapeutics
- AS03- and MF59-Adjuvanted Influenza Vaccines in Children
- (2017) Amanda L. Wilkins et al. Frontiers in Immunology
- Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
- (2017) Masayuki Hayashi et al. EBioMedicine
- The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
- (2017) Pär Comstedt et al. PLoS One
- Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
- (2017) Haipeng Liu et al. Scientific Reports
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
- (2016) Ashesh Gandhi et al. POSTGRADUATE MEDICINE
- Evaluation of potential immunogenicity differences betweenPandemrix™ andArepanrix™
- (2016) Quentin Canelle et al. Human Vaccines & Immunotherapeutics
- Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years
- (2015) Matt Shirley et al. BIODRUGS
- Effect of vaccine administration modality on immunogenicity and efficacy
- (2015) Lu Zhang et al. Expert Review of Vaccines
- High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
- (2015) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
- (2015) Nikolai Petrovsky et al. VACCINE
- The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model
- (2015) Elizabeth B. Norton et al. VACCINE
- Expression, purification, and characterization of theNecator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
- (2015) Christopher A Seid et al. Human Vaccines & Immunotherapeutics
- New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccineNa-APR-1M74
- (2015) Mark S Pearson et al. Human Vaccines & Immunotherapeutics
- Advances in aluminum hydroxide-based adjuvant research and its mechanism
- (2015) Peng He et al. Human Vaccines & Immunotherapeutics
- Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
- (2014) Brandon Feinen et al. Clinical and Vaccine Immunology
- Multiple Low-Dose Challenges in a Rhesus Macaque AIDS Vaccine Trial Result in an Evolving Host Response That Affects Protective Outcome
- (2014) Christian Selinger et al. Clinical and Vaccine Immunology
- The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models
- (2014) J.M.A. van den Brand et al. JOURNAL OF COMPARATIVE PATHOLOGY
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis
- (2014) Pär Comstedt et al. PLoS One
- Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- (2014) David Gordon et al. VACCINE
- Comparative Evaluation of Recombinant Protein Production in Different Biofactories: The Green Perspective
- (2014) Matilde Merlin et al. Biomed Research International
- Recombinant protein expression in Escherichia coli: advances and challenges
- (2014) Germán L. Rosano et al. Frontiers in Microbiology
- Protein production using the baculovirus-insect cell expression system
- (2013) A. Contreras-Gómez et al. BIOTECHNOLOGY PROGRESS
- Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases
- (2013) Natasa Strbo et al. IMMUNOLOGIC RESEARCH
- An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
- (2013) N. Petrovsky et al. JOURNAL OF VIROLOGY
- Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
- (2013) Sofia E. Magnusson et al. VACCINE
- Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
- (2013) Wen-Hsiang Chen et al. Human Vaccines & Immunotherapeutics
- Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Survey of the prevalence of immunization non-compliance due to needle fears in children and adults
- (2012) Anna Taddio et al. VACCINE
- MF59 adjuvant: the best insurance against influenza strain diversity
- (2011) Derek T O’Hagan et al. Expert Review of Vaccines
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
- (2010) Guangyu Zhao et al. Virology Journal
- Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
- (2009) Reynald Tremblay et al. BIOTECHNOLOGY ADVANCES
- Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells
- (2009) Y. He et al. JOURNAL OF IMMUNOLOGY
- Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
- (2009) Pieter P Jacobs et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More